Loading clinical trials...
Loading clinical trials...
The purpose of this research was to uncover the prognostic significance of tertiary lymphoid structures related genes from ccRCC patients with respect to clinical characteristics and outcomes. This of...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Ding-Wei Ye
NCT07117227 · Renal Cell Carcinoma (Kidney Cancer), Renal Cell Carcinoma (RCC), and more
NCT05176483 · Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC), and more
NCT07369505 · Breast Cancer Metastatic, Renal Cell Carcinoma (RCC), and more
NCT07175480 · Renal Cell Carcinoma (RCC), Metastatic Renal Cell Carcinoma (mRCC)
NCT06642220 · Renal Cell Carcinoma (RCC), Radioembolization
Fudan University Shanghai Cancer Center
Shanghai
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions